Bryce Kerlin to Present Cutting-Edge Plasminogen Research at 2026 GRC
Bryce Kerlin, Professor of Pediatrics – Hematology at The Ohio State University, shared a post on LinkedIn:
”I’m excited to present my lab’s work at the Plasminogen Activation and Extracellular Proteolysis GRC, organized by Ze Zheng and Paul Kim in February 2026.
Hope to see you there:
The upcoming 2026 Plasminogen Activation and Extracellular Proteolysis will be taking place February 8-13, 2026, at the Four Points Sheraton / Holiday Inn Express, Ventura, California, USA.
Registration is now open! The conference program highlights the cutting-edge work being conducted in the field. To review the program and apply, please click here.
The deadline to complete registration for this prestigious event will close on January 18, 2026; however, interested applicants should submit their application earlier for consideration.
The 2026 Plasminogen Activation and Extracellular Proteolysis (GRS) Seminar will take place the weekend prior to the GRC and is a wonderful opportunity for graduate students and postdocs to present their research among their peers.
Please share these links with your colleagues and help us spread the word to those who may be interested in attending.”
Keep up with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion